Compare AMRX & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | NVST |
|---|---|---|
| Founded | 2002 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.1B |
| IPO Year | 2018 | 2019 |
| Metric | AMRX | NVST |
|---|---|---|
| Price | $13.06 | $27.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | $14.75 | ★ $25.92 |
| AVG Volume (30 Days) | 1.3M | ★ 2.0M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | 104.31 |
| EPS | 0.22 | ★ 0.28 |
| Revenue | N/A | ★ $2,566,500,000.00 |
| Revenue This Year | $4.48 | $6.67 |
| Revenue Next Year | $7.13 | $3.55 |
| P/E Ratio | ★ $59.61 | $97.73 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.01 | $14.72 |
| 52 Week High | $15.42 | $30.42 |
| Indicator | AMRX | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 55.90 | 56.13 |
| Support Level | $12.50 | $19.29 |
| Resistance Level | $13.54 | $30.18 |
| Average True Range (ATR) | 0.33 | 0.86 |
| MACD | 0.15 | 0.24 |
| Stochastic Oscillator | 87.42 | 83.82 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.